GlassScriptPhysician profile
Cindy Ann Burns
NPI 1326348202
$1,315.57
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $412 · 2022: $347 · 2023: $350 · 2024: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $248.90 | 2021-2023 | |
| Abbvie INC. | $218.55 | 2021-2023 | |
| Exeltis, USA INC. | $167.29 | 2021-2024 | Slynd, Tyblume |
| Evofem Biosciences, INC. | $144.37 | 2021-2024 | Phexxi |
| Therapeuticsmd, INC. | $111.05 | 2021-2022 | |
| Pfizer INC. | $79.33 | 2021-2024 | |
| Astellas Pharma US INC | $76.74 | 2023-2024 | Veozah |
| Avion Pharmaceuticals | $69.57 | 2021-2023 | Balcoltra |
| Exact Sciences Corporation | $46.77 | 2023-2024 | Cologuard Collection Kit |
| Millicent US INC | $31.73 | 2023-2024 | Femring, Intrarosa |
| Glaxosmithkline, LLC. | $28.79 | 2021-2022 | |
| Agile Therapeutics, INC. | $26.95 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $20.13 | 2023 | Vivjoa |
| Myovant Sciences INC. | $17.87 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.00 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.